How salt triggers allergySodium chloride can promote immune responses that have been linked to atopic dermatitis. Researchers have now unraveled the mechanistic details between salt intake and activation of T cells. more ➔
Calypso Biotech cash in €20M Series A fi...Dutch autoimmunity specialist Calypso Biotech BV has raised €20m in a Series A financing co-led by Gilde Healthcare and Inkef Capital and co-financed by Johnson & Johnson Innovation … more ➔
Evotec and HZI join forces in antibiotics...Evotec AG and the Helmholtz Centre for Infection Research (HZI) have joined platforms in order to find novel resistance-breaking antibiotics against Gram-negative bugs. more ➔
First immunotolerant allogenic cell transp...Researchers for the first time have found a way to prevent immune rejection of allogenic iPSC-derived cell and tissue transplants. more ➔
Arvelle Therapeutics raises $180m in Serie...Swiss newco Arvelle Therapeutics has baged a $180m (€159.1m) series A financing led by LSP. The company licenced the anti-epileptic candidate cenobamate (YKP3089) for $100m (€88.4m) upfront … more ➔
Bio-plastics production grows to 7.5 milli...The market for bio-based building blocks and polymers showed moderate growth to 7.5 million tonnes in 2018 and will grow with a CGAR of 4% by 2023 reports German nova-Institute. more ➔
Reprogrammed pancreatic cells cure type I...Swiss researchers have demonstrated a way to cure type I diabetes without cell transplantation. In model mice the reprogrammed non-islet cells from human pancreas more ➔
Afyren raises €21m to launch production...French industrial biotech company Afyren announced a capital increase of €21m in a financing round led by Sofinnova Partners and Valquest Partners to scale up its biobased organic acid production … more ➔
Industrial biotech hub validates start-up...Biotech Campus Delft, Royal DSM and YES!Delft partner up have launched a Biotech Validation Lab to validate the business concepts of European biotech startups. more ➔
uniqure delivers POC for hemophilia B gene...Gene therapy uniQure NV (Amsterdam) reported that factor IX levels of patients with severe hemophilia B raised to a mean of 38% of normal 12 weeks after a single injection of AMT-061. more ➔
